Research ArticleHuman Studies
Comparison of Complete Versus Fragmented Technetium-99m-Labeled Anti-CEA Monoclonal Antibodies for Immunoscintigraphy in Colorectal Cancer
Thomas M. Behr, Wolfgang S. Becker, Hans-J. Bair, Michael W. Klein, Christine M. Stühler, Klaus P. Cidlinsky, Christian W. Wittekind, Johannes R. Scheele and Friedrich G. Wolf
Journal of Nuclear Medicine March 1995, 36 (3) 430-441;
Thomas M. Behr
Wolfgang S. Becker
Hans-J. Bair
Michael W. Klein
Christine M. Stühler
Klaus P. Cidlinsky
Christian W. Wittekind
Johannes R. Scheele


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Comparison of Complete Versus Fragmented Technetium-99m-Labeled Anti-CEA Monoclonal Antibodies for Immunoscintigraphy in Colorectal Cancer
Thomas M. Behr, Wolfgang S. Becker, Hans-J. Bair, Michael W. Klein, Christine M. Stühler, Klaus P. Cidlinsky, Christian W. Wittekind, Johannes R. Scheele, Friedrich G. Wolf
Journal of Nuclear Medicine Mar 1995, 36 (3) 430-441;
Comparison of Complete Versus Fragmented Technetium-99m-Labeled Anti-CEA Monoclonal Antibodies for Immunoscintigraphy in Colorectal Cancer
Thomas M. Behr, Wolfgang S. Becker, Hans-J. Bair, Michael W. Klein, Christine M. Stühler, Klaus P. Cidlinsky, Christian W. Wittekind, Johannes R. Scheele, Friedrich G. Wolf
Journal of Nuclear Medicine Mar 1995, 36 (3) 430-441;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Targeting of Lectinlike Oxidized Low-Density Lipoprotein Receptor 1 (LOX-1) with 99mTc-Labeled Anti-LOX-1 Antibody: Potential Agent for Imaging of Vulnerable Plaque
- Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer
- FDG PET and Immunoscintigraphy with 99mTc-Labeled Antibody Fragments for Detection of the Recurrence of Colorectal Carcinoma
- Chemical Design of Radiolabeled Antibody Fragments for Low Renal Radioactivity Levels